The future of cancer treatment – combining stem cells and immunotherapy.
The company leads a Department of Industry, Innovation and Science Co-operative Research Centre project in partnership with the Hudson Institute of Medical Research, Monash University, Mesoblast Ltd and Cell Therapies Pty Ltd.
Cartherics is:
- Creating a new class of cancer treatments beyond surgery, chemotherapy, biologicals and radiation.
- Supercharging a patient’s own immune system, helping it eliminate cancer.
- Developing accessible ‘off-the-shelf’ immunotherapies to fight aggressive forms of cancers like relapsed ovarian and gastric cancers.
Transforming cancer from a fatal disease to a manageable condition.
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-8332
-
- There are more pages in this discussion • 9,914 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.21 |
Change
0.040(3.42%) |
Mkt cap ! $1.381B |
Open | High | Low | Value | Volume |
$1.17 | $1.22 | $1.17 | $5.683M | 4.776M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | $1.21 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.21 | 19746 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 1.205 |
2 | 55500 | 1.200 |
3 | 60292 | 1.195 |
1 | 33180 | 1.190 |
3 | 67965 | 1.185 |
Price($) | Vol. | No. |
---|---|---|
1.210 | 19746 | 3 |
1.215 | 45236 | 7 |
1.220 | 190559 | 15 |
1.225 | 70181 | 4 |
1.230 | 169274 | 5 |
Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online